Want to join the conversation?
Medical technology, services and solutions company $MDT said the U.S. Food and Drug Administration has approved its Investigational Device Exemption application for the pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) study. The study will include approx. 120 adult patients with drug-resistant MTLE.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?